Carregant...
The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia
PURPOSE: To assess ibrutinib pharmacokinetics under fasted and fed conditions, impact of food-intake timing, and the safety and tolerability. METHODS: Three studies were analyzed. Study 1 was a randomized, open-label, single-dose, four-way crossover study in 44 healthy participants. Study 2 was a ra...
Guardat en:
Publicat a: | Cancer Chemother Pharmacol |
---|---|
Autors principals: | , , , , , , , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Springer Berlin Heidelberg
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419161/ https://ncbi.nlm.nih.gov/pubmed/25724156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-015-2708-9 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Carregant...